Compare GTY & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTY | NEOG |
|---|---|---|
| Founded | 1955 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1998 | 1995 |
| Metric | GTY | NEOG |
|---|---|---|
| Price | $32.66 | $9.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $32.60 | $10.67 |
| AVG Volume (30 Days) | 342.4K | ★ 2.7M |
| Earning Date | 04-22-2026 | 04-09-2026 |
| Dividend Yield | ★ 5.85% | N/A |
| EPS Growth | ★ 8.00 | N/A |
| EPS | ★ 0.43 | 0.02 |
| Revenue | $221,727,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $9.39 | N/A |
| Revenue Next Year | $7.83 | N/A |
| P/E Ratio | ★ $77.17 | $468.00 |
| Revenue Growth | ★ 9.02 | N/A |
| 52 Week Low | $25.39 | $4.53 |
| 52 Week High | $34.75 | $11.43 |
| Indicator | GTY | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 42.95 |
| Support Level | $31.56 | $8.98 |
| Resistance Level | $34.08 | $10.12 |
| Average True Range (ATR) | 0.69 | 0.39 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 8.88 | 4.64 |
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.